Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs.

Biotechnology

Tryp Therapeutics

Larry Norder

Michael Silverman

Jim O'neill

Peter Guzzo

Jason Carroll

The executive team at Tryp Therapeutics has a history of working in biotech startups and venture capital. They have a combined education in finance and chemical engineering from UCLA Anderson School of Management and Brigham Young University.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Other teams at Tryp Therapeutics

Board of Directors

Leadership Team